Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
<IPO>MEDTIDE (03880.HK) Begins IPO Tdy w/ Entry Fee $3,091, Introduces CSPC PHARMA as Cornerstone Investor
Recommend 20 Positive 33 Negative 13 |
||||
|
||||
|
CRDMO MEDTIDE (03880.HK) announced details of its Hong Kong IPO, planning to globally offer 16.8 million H shares, with 10% (approx. 1.68 million shares) for Hong Kong public offering and 90% (15.12 million shares) for international placement. The offer price ranges from $28.4 to $30.6 per share, aiming to raise a maximum amount of approx. $514 million. The entry fee for a board lot of 100 shares is around $3,090.85. The offering period starts today (20th), and will end next Wednesday (25th), with listing expected on 30 June. Morgan Stanley and CITIC Securities are its joint sponsors. In this IPO, MEDTIDE introduced CSPC PHARMA (01093.HK) and Welight Capital, founded by former TENCENT (00700.HK) executive Wu Xiaoguang, as cornerstone investors, subscribing shares equivalent to US$5 million each. AASTOCKS Financial News Website: www.aastocks.com |
||||
Copied to Clipboard
 |
||||
